Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Continuation rates of levetiracetam in children from the EULEVp cohort study.

Dureau-Pournin C, Pédespan JM, Droz-Perroteau C, Lavernhe G, Mann M, Pollet C, Robinson P, Jové J, Moore N, Fourrier-Réglat A; EULEV study group..

Eur J Paediatr Neurol. 2014 Jan;18(1):19-24. doi: 10.1016/j.ejpn.2013.07.003. Epub 2013 Sep 10.

PMID:
24035600
2.

The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.

Droz-Perroteau C, Dureau-Pournin C, Vespignani H, Marchal C, Blin P, Blazejewski S, Pollet C, Jové J, Robinson P, Moore N, Fourrier-Réglat A; EULEV Study Group..

Br J Clin Pharmacol. 2011 Jan;71(1):121-7. doi: 10.1111/j.1365-2125.2010.03805.x.

3.

Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.

Droz-Perroteau C, Marchal C, Dureau-Pournin C, Lassalle R, Jové J, Robinson P, Lavernhe G, Vespignani H, Moore N, Fourrier-Réglat A; Eulev Study Group..

Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1183-9. doi: 10.1002/pds.3338. Epub 2012 Sep 13.

PMID:
22972760
4.

Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.

Goldberg-Stern H, Feldman L, Eidlitz-Markus T, Kramer U, Perez S, Pollak L, Phatal-Valevski A.

Eur J Paediatr Neurol. 2013 May;17(3):248-53. doi: 10.1016/j.ejpn.2012.10.008. Epub 2012 Nov 16.

PMID:
23159714
5.

Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.

Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.

Eur J Paediatr Neurol. 2008 Jul;12(4):321-7. Epub 2007 Oct 18.

PMID:
17950011
6.

Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.

Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP.

Epilepsy Behav. 2007 Mar;10(2):296-303. Epub 2007 Feb 20.

PMID:
17317325
7.

Levetiracetam monotherapy in children with epilepsy.

Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A.

Pediatr Neurol. 2007 Apr;36(4):227-30.

PMID:
17437904
8.

A prospective study of levetiracetam efficacy in epileptic syndromes with continuous spikes-waves during slow sleep.

Atkins M, Nikanorova M.

Seizure. 2011 Oct;20(8):635-9. doi: 10.1016/j.seizure.2011.06.007. Epub 2011 Jul 12.

9.

[Levetiracetam in the treatment of epilepsy].

Mariero Klees T, Brodtkorb E, Nakken KO, Lossius R, Johannessen SI.

Tidsskr Nor Laegeforen. 2003 May 29;123(11):1539-41. Norwegian.

10.

Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up.

Kuba R, Novotná I, Brázdil M, Kocvarová J, Tyrlíková I, Mastík J, Rektor I.

Acta Neurol Scand. 2010 Feb;121(2):83-8. doi: 10.1111/j.1600-0404.2009.01257.x. Epub 2009 Dec 10.

PMID:
20003081
11.

[Experience with levetiracetam in childhood epilepsy].

Neuwirth M, Saracz J, Hegyi M, Paraicz E, Kollár K, Móser J, Rosdy B, Herczegfalvi A, Fogarasi A.

Ideggyogy Sz. 2006 May 20;59(5-6):179-82. Hungarian.

PMID:
16786712
12.

Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.

Li S, Cao J, Xiao N, Cai F.

J Child Neurol. 2010 May;25(5):609-13. doi: 10.1177/0883073809342489. Epub 2009 Sep 24.

PMID:
19779208
13.

[Experience with levetiracetam in the treatment of childhood refractory epilepsy].

Doumbia-Ouattara M, Bourel-Ponchel E, Le Moing AG, Querne L, Delignières A, de Broca A, Berquin P.

Arch Pediatr. 2012 Jan;19(1):3-8. doi: 10.1016/j.arcped.2011.10.017. Epub 2011 Dec 12. French.

PMID:
22169571
14.

A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy.

Nakken KO, Eriksson AS, Lossius R, Johannessen SI.

Seizure. 2003 Jan;12(1):42-6.

15.

Levetiracetam in pediatrics.

Vigevano F.

J Child Neurol. 2005 Feb;20(2):87-93. Review.

PMID:
15794171
16.

Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.

Lee YJ, Kang HC, Kim HD, Lee JS.

Pediatr Neurol. 2010 Feb;42(2):86-92. doi: 10.1016/j.pediatrneurol.2009.08.002.

PMID:
20117743
17.

Long-term levetiracetam treatment of epilepsy patients: clinical audit.

Kuba R, Novotná I, Brázdil M, Kocvarová J, Tyrliková I, Mastík J, Rektor I.

Epilepsy Res. 2006 Dec;72(2-3):111-9. Epub 2006 Aug 22.

PMID:
16930945
18.

[Clinical experience with levetiracetam for adults with epilepsy].

Barcs G, Szucs A.

Ideggyogy Sz. 2007 Jan 20;60(1-2):31-4. Hungarian.

PMID:
17432091
19.

Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.

McTague A, Kneen R, Kumar R, Spinty S, Appleton R.

Seizure. 2012 Sep;21(7):529-34. doi: 10.1016/j.seizure.2012.05.010. Epub 2012 Jun 19.

20.

Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.

Chaisewikul R, Privitera MD, Hutton JL, Marson AG.

Cochrane Database Syst Rev. 2001;(1):CD001901. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD001901.

PMID:
11279737

Supplemental Content

Support Center